Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DX25FVFSD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $45,848
Award facts
- Contract value 100% obligated
- $45,847.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dupixent 300 mg/2 mL pens with a firm fixed price ceiling value of $45,847.85 and an ultimate completion date of June 3, 2025. This non-set-aside, competitively awarded delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major healthcare solutions provider serving federal medical procurement needs.
As a critical vendor for military and veteran healthcare systems, AmerisourceBergen leverages its comprehensive pharmaceutical distribution network to fulfill federal medical supply requirements across multiple therapeutic domains. The SPE2DX indefinite delivery vehicle serves as a global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other government healthcare systems. This delivery order for Dupixent, a specialty pharmaceutical used in dermatological and immunological treatments, represents the company's continued role in providing specialized medical commodities to support military healthcare programs.
Quick answers
Who was awarded contract SPE2DX25FVFSD?
SPE2DX25FVFSD was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on June 2, 2025.
How much is contract SPE2DX25FVFSD worth?
The government has obligated $45,848 on SPE2DX25FVFSD.
Is contract SPE2DX25FVFSD an order under another contract?
Yes. SPE2DX25FVFSD is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVFSD competed?
The extent of competition for SPE2DX25FVFSD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award